In recent years pyrimidine derivatives have received signifi cant attention owing to their diverse range of biological properties particularly being antifungal 1 , antitubercular 2 , antibacterial 3, 4 , antiviral [5] [6] [7] [8] , anticancer 9 and antioxidant 10 . 2,5-Disubstituted-1,3,4-thiadiazoles represent one of the most active classes of compounds possessing wide spectrum of biological activities. 2,5-Disubstituted-1,3,4-thiadiazole derivatives exhibit in vitro antimycobacterial 11 , antibacterial 12 , anticancer 13, 14 and antioxidant 15 properties. Considering the above facts, the goal of the present study was to combine disubstituted pyrimidines with 1,3,4-thiadiazole residues in order to develop hybrid molecules with potential of enhanced activity and to test their antioxidant and antitumor activities.
Melting points were taken in open capillary tubes and are uncorrected. The IR spectra (KBr, cm -1 ) were recorded on a Shimadzu FTIR 800 series spectrophotometer and 1 H NMR spectra (CDCl 3 ) on Varian EM 390 MHz spectrometer using TMS as internal standard. Mass spectra were recorded on Shimadzu 2010A LC-MS system. The reactions were monitored by thin layer chromatography using silica gel plates and detected by UV chamber and iodine as visualizing agent. The purity of the compounds was checked on silica gel precoated plates. All the solvents used were purifi ed according to the standard methods 16 . Phenyl isothiocyanate was prepared according to the standard method 17 .
For the preparation of 4, 6-disubstituted pyrimidine-2-thiols (2a-i) a mixture of appropriate chalcones (1a-i, Scheme 1) (0.01 mol) and thiourea (0.01 mol) in ethanol (50 ml) and sodium hydroxide (0.01 mol) dissolved in minimum quantity of water was refl uxed on a water bath for 12 h and poured into 250 ml of cold water. The solid that separated in each case was filtered, washed with water and recrystallized from ethyl acetate (Table 1) For preparation of 2-[(4, 6-disubstituted pyrimidine-2-yl) thio] acetyl-N-phenylhydrazine carbothiamide (5a-c), a mixture of the acid hydrazides (4a-c) (0.01 mol) and phenylisothiocyanate (0.0015 mol) in ethanol (10 ml) was refluxed on a water bath for about 8 h. The solution was allowed to reach ambient temperature and the resulting solid in each case was collected and recrystallized from methanol ( For preparation of 5-{[(4,6-disubstituted pyrimidine-2-yl) thio] methyl}-N-phenyl-1,3,4-thiadiazol-2-amine (6a-c), a mixture of the appropriate thiosemicarbazides (5a-c) (0.001 mol) in cold concentrated sulphuric acid (3 ml) was stirred for 10 min the resulting solution was then allowed to reach ambient temperature and poured cautiously into ice cold water. The reaction mixture was made alkaline to pH 8 with aqueous ammonia and the precipitated product in each case was collected washed with cold water and recrystallized from ethanol (Table 1) Determination of In vitro antioxidant activity was done by DPPH (1,1-diphenyl-2-picrylhydrazyl) 18 and nitric oxide 19 free radical scavenging methods. The methods were used to screen compounds (2a-i) and (6a-c) for the antioxidant activity. Ascorbic acid and rutin were used as reference standards at a concentration level of 100 g/ml. Results are presented in Table 2 .
Antitumor activity of the compounds was evaluated by tryphan blue dye exclusion technique 20 against human breast cancer MCF-7 cell line at 20 M concentration. Primary screening of the compounds was done to indicate whether a substance possessed enough activity at this concentration to inhibit cell growth by 50%. Results are presented in Table 2 .
Chalcones (1a-i) required as starting material were prepared 21 by stirring equimolar solution of various substituted acetophenones and araldehydes in the presence of sodium hydroxide in ethanol at room temperature (Scheme 1). Solution in ethanol of chalcones (1a-i) and thiourea in the presence of Table 1 . In the IR spectrum of 2b, the presence of band at 2840 cm -1 (SH) and the absence of band due to >C=O confi rmed the formation of pyrimidine-2-thiol moiety. The appearance of singlet at δ 9.72 due to SH also confi rmed the formation of 2b. The IR spectrum of 5b exhibited band at 1681 cm -1 (>C=O), 1667 cm -1
(>C=N) and 3120-3218 cm -1 due to N-H. The 1 H NMR spectrum of 5b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-7.92 and a multiplet integrating for 3 protons from δ 8.20-10.12 due to NH.NH. CS.NH. In the IR spectrum of 6b, the disappearance of bands at 1681 cm -1 (>C=O) and 1453 cm -1 (>C=S) and the appearance of band at 746 cm -1 (C-S-C) confi rmed the formation of thiadiazole ring. The 1 H NMR spectrum of 6b exhibited the aromatic and heterocyclic protons as a multiplet integrating for 15 protons from δ 7.21-8.32 and a singlet at δ 9.3 integrating for one proton due to NH. In the mass spectra, the molecular ion peak at 483 (M + ) also confi rmed the formation of titled compound 6b.
Compound 2c, 2d, 2g and 6b showed moderate DPPH free radical scavenging activity while all other compounds were found to be less active. Compounds 2c, 2d and 6b showed moderate nitric oxide free radical scavenging activity and all other compounds were found to be less active. As shown in Table 2 compounds 2b, 2c and 6b exhibited signifi cant activity against human breast cancer MCF-7 cell line, while compounds 2e and 2h showed moderate cytotoxicity.
